2k Clinical Consulting, Inc.

Menu

CAPA

Root Cause Analysis for CAPA: 5 Steps to Inspection Readiness

by

In today’s fast-paced regulatory landscape, being inspection-ready isn’t optional—it’s essential. A strong Root Cause Analysis (RCA) process can mean the difference between repeat deviations and long-term excellence. RCA is more than just a quality requirement—it’s the foundation of an effective Corrective and Preventive Action (CAPA) system.  Here are five (5) steps to establishing a solid RCA process:

Step 1: Define the Problem Accurately

Every strong CAPA begins with a clear, documented problem statement. Avoid vague terms like “operator error.” Instead, outline:

  • What occurred

  • Where and when it happened

  • How it was detected

Need help framing your investigation? Check out Understanding the CAPA Process to align with industry expectations.

Step 2: Collect Supporting Data

Gather all relevant evidence: audit logs, deviation reports, interviews, and batch records. Thorough documentation not only strengthens your RCA—it shows FDA inspectors you take quality seriously.

Step 3: Identify and Verify the Root Cause

Use tools like:

  • 5 Whys

  • Fishbone (Ishikawa) diagrams

Be honest: are you solving the real problem, or just the visible one? Learn how to go deeper with Getting to the Core of the CAPA System – The Root Cause Analysis.

Step 4: Build a Robust CAPA Plan

Once root cause is verified:

  • Correct the immediate issue (e.g., isolate affected materials, issue a stop order).

  • Corrective Action: Revise SOPs, retrain staff, and automate error-prone steps.

  • Preventive Action: Introduce monitoring dashboards, conduct follow-ups at 3- and 6-month intervals.

Make sure your plan is SMART: Specific, Measurable, Achievable, Relevant, and Time-bound.

Step 5: Monitor and Sustain Results

Your CAPA is only as good as its outcome tracking. Monitor metrics such as:

  • Repeat deviation rate

  • CAPA closure time

  • Training effectiveness scores

Regular reviews don’t just keep your system clean—they give you confidence during unannounced audits.

Pro Tip: Conduct a CAPA Dry Run

Treat one of your internal issues like a mock FDA audit. Document each step from problem definition through CAPA closure. Then evaluate: Would this satisfy an inspector? This exercise trains your team and uncovers process blind spots—before an actual audit exposes them.

 

 

Build Your Inspection-Ready Toolkit

Root Cause Analysis isn’t just about solving a problem—it’s about building a culture of prevention.

✅Ready for a little challenge? Here’s your next step:
Take 30 minutes this week to walk through your last deviation or audit finding using the full RCA-to-CAPA lifecycle.

Then ask yourself:

  • Did we stop at the symptom—or get to the true root?

  • Have our corrective actions actually prevented recurrence?

  • Would this stand up to an FDA inspection or internal audit today?

💬 We want to hear from you!
Reply to this article with your biggest challenge when applying RCA or sustaining preventive actions. Your insights could help shape our next guide or training tool—and help others improve, too.

And if you haven’t yet, explore these next:

Together, we’re building smarter systems, stronger teams, and inspection-ready organizations—one finding at a time.

Understanding the CAPA Process

by

A corrective and preventive action (CAPA) plan is a set of steps done to address a compliance problem and, more significantly, to keep it from happening again. The immediate noncompliance and the broader nature of the problem will be the subject of a CAPA plan. It entails investigating the root cause and comprehending the problem, finding a solution, and ultimately avoiding recurrence. CAPA systems are important in clinical trials as it can be used to

  1. Address audit or inspection findings,
  2. Improve compliance and
  3. Reduce risk.

Importance of CAPA System in Clinical Trial Settings

During the clinical trial process, compliance to the GCP quality standard ensures that the information and drawn conclusions are credible and correct, as well as that the trial subjects’ rights, integrity, and confidentiality are safeguarded. The CAPA system ensures that the aforementioned conditions are met.

But how can we ensure that we are following the right steps? Read ahead about the phases of the CAPA system.

Phases in Implementation of the CAPA System

Before you start a clinical trial, keep in mind the following phases to implement a successful CAPA system.

  1. CAPA Initiation and Problem Identification: To begin the CAPA process, the problem identification and commencement phase needs recording the issue. The description should include who, what, when, where, why, and how many people were involved. A detailed report is favorable.
  2. Risk Analysis: A risk analysis should be conducted based on the risk to the patient, user, business, and compliance. CAPA deadlines should be determined by the outcomes of the risk analysis. Low-risk problems, obviously, will not have the same sense of urgency as high-risk problems.
  3. Correction: To prevent additional deviations or discrepancies, correction  should be undertaken as early as possible. To identify if there are any systemic difficulties, the organization should examine linked processes and products.
  4. Root Cause Analysis & Investigation: The following are some of the most commonly used tools/methods for conducting investigations to find the underlying cause of a problem;
    1. Flowcharting
    2. Brainstorming
    3. Affinity diagrams
    4. Fishbone diagrams
  5. Corrective or Preventive Actions: Corrective and preventative activities are long-term strategies for resolving or eliminating the cause of a nonconformity or a possible nonconformity.
  6. Implementation: Corrective and preventative actions are initiated and implemented during the implementation phase to address the root cause or causes of a nonconformity. Procedural upgrades, training, and process improvements are just a few examples.
  7. Verification of Implementation or VOI: VOIs are used to ensure that promised and planned corrections, containment, corrective actions, and preventive actions were carried out.
  8. Verification of Effectiveness Plan (VOEP): The effectiveness plan phase establishes and defines preset criteria for determining whether corrective and/or preventive activities were successful.
  9. Verification of Effectiveness (VOE): The verification of effectiveness phase entails analysing and recording the VOE plan’s stated criteria. A successful effectiveness verification should show that the genuine root cause of the problem was correctly identified and that the remedial and/or preventive actions were helpful.
  10. Closure: This is the final step in the CAPA procedure. Only once the verification of efficacy has been satisfactorily performed should a CAPA be closed. If a CAPA is discovered to be unsuccessful, it is recommended starting a new one while referencing the old one.

Conclusion

CAPAs are required by regulations, standards, and guidelines by health authorities across the globe.  Having a CAPA system in place assists a clinical trial by strengthening its market advantage, reducing unnecessary costs and improving processes if completed appropriately. To ensure that the process phases are clearly defined, each phase of a CAPA should be its own part on a form as an electronic workflow.

Struggling with creating effective CAPAs for your site or department?  Contact us! We’d love to hear from you to discuss strategies!

Our Mission and Purpose

The mission of 2K Clinical Consulting, Inc. is to ease the burden of GxP compliance and to transform the effectiveness of professionals and compliance systems worldwide.

Our History

2K Clinical Consulting, Inc. is the vision of former FDA Investigator, Kimberly Kiner, who empathized with facilities and sites that struggled with understanding and complying with regulations. After years in the field, Kimberly transitioned into the private sector and acquired international experience in compliance, monitoring and study management while she worked for pharmaceutical and invitro/medical device companies as well as CROs. This work experience is what sparked her desire to work as a consultant for organizations such as the Association for Clinical Research Professionals and the Society of Clinical Research Associates. Kimberly later went on to train providers such as Compliance Online and Fx Conferences. This exposure became the gateway to connecting with other experts and teaching professionals resulting in an engaging experience for clients that closes the gap in best practices within the realm of compliance.